Gilead's lenacapavir reduced HIV infections by 96% in trial

A pharmacist holds a bottle of lenacapavir, the new injectable drug for HIV prevention. Nardus Engelbrecht | AP GileadPfizer's twice-yearly…

Noom to offer GLP-1 drug through new weight loss program

Digital health company Noom announced Thursday that it will offer a compounded GLP-1 drug as part of a new weight-loss…